| Title : The Cholinergic Drug Galantamine Alleviates Oxidative Stress Alongside Anti-inflammatory and Cardio-Metabolic Effects in Subjects With the Metabolic Syndrome in a Randomized Trial - Sangaleti_2021_Front.Immunol_12_613979 |
| Author(s) : Sangaleti CT , Katayama KY , De Angelis K , Lemos de Moraes T , Araujo AA , Lopes HF , Camacho C , Bortolotto LA , Michelini LC , Irigoyen MC , Olofsson PS , Barnaby DP , Tracey KJ , Pavlov VA , Consolim Colombo FM |
| Ref : Front Immunol , 12 :613979 , 2021 |
| Abstract : Sangaleti_2021_Front.Immunol_12_613979 |
| ESTHER : Sangaleti_2021_Front.Immunol_12_613979 |
| PubMedSearch : Sangaleti_2021_Front.Immunol_12_613979 |
| PubMedID: 33776997 |
Sangaleti CT, Katayama KY, De Angelis K, Lemos de Moraes T, Araujo AA, Lopes HF, Camacho C, Bortolotto LA, Michelini LC, Irigoyen MC, Olofsson PS, Barnaby DP, Tracey KJ, Pavlov VA, Consolim Colombo FM (2021)
The Cholinergic Drug Galantamine Alleviates Oxidative Stress Alongside Anti-inflammatory and Cardio-Metabolic Effects in Subjects With the Metabolic Syndrome in a Randomized Trial
Front Immunol
12 :613979
Sangaleti CT, Katayama KY, De Angelis K, Lemos de Moraes T, Araujo AA, Lopes HF, Camacho C, Bortolotto LA, Michelini LC, Irigoyen MC, Olofsson PS, Barnaby DP, Tracey KJ, Pavlov VA, Consolim Colombo FM (2021)
Front Immunol
12 :613979